Stockreport

Cingulate to Participate in Benzinga All Live Access Event

Cingulate Inc.  (CING) 
PDF KANSAS CITY, Kan., March 19, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PT [Read more]